Back To Active Research

Development of Caregiver Reported Outcome Measures for NDD

The purpose of this study is to develop and validate a disease-specific, observer-reported outcome measure for clinical trials of patients with the following Neurodevelopmental Disorders (NDDs): SYNGAP1 and RAI1 deficiencies (such as SMS), and Fragile X Syndrome. The study is being conducted in multiple phases.

For more information, please click on the info graphic below to open an information sheet for this study and to learn more about how you can participate in this study.